Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Alimentary Pharmacology & Therapeutics|October 5, 2011
Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseasesA Oussalah, J-L Guéant, L Peyrin-Biroulet
Gastroenterologie Clinique Et Biologique|January 3, 2009
TNF antagonists in the treatment of inflammatory bowel disease: results of a survey of gastroenterologists in the French region of LorraineL Peyrin-Biroulet, A Oussalah, T Boucekkine, et al.
Alimentary Pharmacology & Therapeutics|January 22, 2011
The use of azathioprine in Crohn's disease during pregnancy and in the post-operative setting: a worldwide survey of expertsL Peyrin-Biroulet, A Oussalah, X Roblin, et al.
Alimentary Pharmacology & Therapeutics|November 3, 2010
Additional benefit of procalcitonin to C-reactive protein to assess disease activity and severity in Crohn's diseaseA Oussalah, V Laurent, O Bruot, et al.
Alimentary Pharmacology & Therapeutics|July 9, 2009
Long-term outcome of non-fistulizing (ulcers, stricture) perianal Crohn's disease in patients treated with infliximabG Bouguen, I Trouilloud, L Siproudhis, et al.
Alimentary Pharmacology & Therapeutics|September 22, 2009
Tumour necrosis factor antagonists and inflammatory bowel diseases: a national practice surveyA Oussalah, X Roblin, D Laharie, et al.
Alimentary Pharmacology & Therapeutics|November 28, 2008
Adalimumab for Crohn's disease with intolerance or lost response to infliximab: a 3-year single-centre experienceA Oussalah, A Babouri, J-B Chevaux, et al.
Gastroenterologie Clinique Et Biologique|November 10, 2009
Inflammatory bowel disease and hepatitis B and CJ-B Chevaux, M-A Bigard, M Bensenane, et al.
Alimentary Pharmacology & Therapeutics|July 26, 2008
Long-term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single-centre experienceA Oussalah, C Laclotte, J-B Chevaux, et al.
Gastroenterologie Clinique Et Biologique|July 16, 2008
[Helminths and inflammatory bowel diseases]C Laclotte, A Oussalah, P Rey, et al.
Pageof 2